Navigation Links
Scientists Map Intestinal Bug's Genome
Date:9/27/2007

Giardia is leading cause of parasitic infections in U.S.

THURSDAY, Sept. 27 (HealthDay News) -- Scientists have sequenced the genome of the intestinal parasite Giardia lamblia, responsible for more than 20,000 reported infections a year in the United States.

That makes giardia the most common intestinal parasite identified by public health laboratories in the country, experts note.

People contract Giardia through contact with infected stool or by drinking water contaminated with the parasite, which most often strikes hikers and other outdoor enthusiasts, as well as children in daycare. Symptoms include nausea, diarrhea, bloating and abdominal cramping.

The genome was sequenced by an international team of scientists. It's described in the Sept. 28 issue of the journal Science.

Analysis of the parasite's genome has already provided more insight on the parasite's evolution and revealed possible new targets for treatment.

"Existing drugs can effectively treat people with Giardia infections, but, as with many pathogens, the concern is that the parasite will develop resistance to these medications," Dr. Anthony S. Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), said in a prepared statement. "The Giardia lamblia genome shows us that the parasite has a large complement of unusual proteins that are potential targets for new drugs or vaccines."

The NIAID funded the effort to sequence the parasite's genome.

More information

The U.S. Centers for Disease Control and Prevention has more about Giardia infection.



-- Robert Preidt



SOURCE: U.S. National Institute of Allergy and Infectious Diseases, news release, Sept. 25, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack mechanism of Leptin-Obesity Hormone
4. Scientists use plant hormones to fight cancer
5. American scientists alter gene makeup of babies
6. Expose on eating disorders!! Scientists trace “brain’s eating control center pathway”
7. Scientists found ancient Human Germ Killer
8. Scientists locate key hormone involved in appetite control
9. Scientists open the book of life
10. Electronic nose by Italian scientists
11. Scientists review SARS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... Spectrum Aquatics has launched a brand new ADA pool lift, the ... the user in mind. , “Over the last two years our key customers and ... lbs lift is a necessary requirement for certain facilities with specific needs,” said Nabil ...
(Date:5/31/2016)... ... May 31, 2016 , ... TeaZa® Energy, LLC ... pouches, on World No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will ... on this summer. , The new flavor is best described as a juicy, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... marketing services firm and statement solutions provider, for the tenth consecutive year ... May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in the “U.S. ...
(Date:5/30/2016)... FL (PRWEB) , ... May 30, 2016 , ... As ... means for their children and their efforts to keep their households lice free. ... across Hawaii are enacting new policies that keep kids in the classroom despite the ...
(Date:5/30/2016)... , ... May 30, 2016 , ... Another ER facility ... in Plano, located at 3960 Legacy Drive, Plano, TX and is open 24 hours ... of Commerce followed by a medical open house. The Jasper High School band entertained ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... Eye expert s ... eye examination before leaving hospital ... Moorfields Eye Hospital Dubai, the first overseas branch of the ... identified premature babies as a special concern in the region when ... retinopathy of prematurity (ROP). ROP is a potentially blinding condition that ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
Breaking Medicine Technology: